Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
about
Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Named Patient Use Program to P ...... nt of Metastatic Breast Cancer
@en
type
label
Named Patient Use Program to P ...... nt of Metastatic Breast Cancer
@en
prefLabel
Named Patient Use Program to P ...... nt of Metastatic Breast Cancer
@en
P17
P6153
P1476
Named Patient Use Program to P ...... nt of Metastatic Breast Cancer
@en
P3098
NCT03763604